Ainhoa Hernández

580 total citations
21 papers, 252 citations indexed

About

Ainhoa Hernández is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, Ainhoa Hernández has authored 21 papers receiving a total of 252 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 8 papers in Genetics. Recurrent topics in Ainhoa Hernández's work include Glioma Diagnosis and Treatment (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Cancer Genomics and Diagnostics (6 papers). Ainhoa Hernández is often cited by papers focused on Glioma Diagnosis and Treatment (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Cancer Genomics and Diagnostics (6 papers). Ainhoa Hernández collaborates with scholars based in Spain. Ainhoa Hernández's co-authors include Marta Doménech, Carmen Balañá, Andrea Plaja, Eva Martinez‐Balibrea, Cristina Carrato, Teresa Morán, Ana M Muñoz‐Mármol, Estela Pineda, Maria Saigí and Enric Carcereny and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Oncotarget.

In The Last Decade

Ainhoa Hernández

21 papers receiving 252 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ainhoa Hernández Spain	8	99	95	87	56	47	21	252
Madison Butler United States	4	120 1.2×	82 0.9×	136 1.6×	39 0.7×	50 1.1×	8	256
Andrea Franson United States	8	84 0.8×	59 0.6×	107 1.2×	36 0.6×	48 1.0×	23	193
Michaël H. Meel Netherlands	13	172 1.7×	65 0.7×	153 1.8×	68 1.2×	41 0.9×	20	367
Sho Tamai Japan	10	93 0.9×	55 0.6×	85 1.0×	43 0.8×	27 0.6×	25	237
Leire Pedrosa Spain	8	81 0.8×	58 0.6×	33 0.4×	79 1.4×	33 0.7×	29	240
Lisa Mayr Austria	9	121 1.2×	43 0.5×	77 0.9×	71 1.3×	50 1.1×	25	239
Claire Faulkner United Kingdom	10	145 1.5×	72 0.8×	204 2.3×	34 0.6×	63 1.3×	13	324
Ophélie Renoult France	8	157 1.6×	121 1.3×	103 1.2×	56 1.0×	19 0.4×	12	290
Wojciech Szopa Poland	5	136 1.4×	118 1.2×	151 1.7×	52 0.9×	79 1.7×	8	339

Countries citing papers authored by Ainhoa Hernández

Since Specialization

Citations

This map shows the geographic impact of Ainhoa Hernández's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ainhoa Hernández with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ainhoa Hernández more than expected).

Fields of papers citing papers by Ainhoa Hernández

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ainhoa Hernández. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ainhoa Hernández. The network helps show where Ainhoa Hernández may publish in the future.

Co-authorship network of co-authors of Ainhoa Hernández

This figure shows the co-authorship network connecting the top 25 collaborators of Ainhoa Hernández. A scholar is included among the top collaborators of Ainhoa Hernández based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ainhoa Hernández. Ainhoa Hernández is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Muñoz‐Mármol, Ana M, Bárbara Meléndez, Ainhoa Hernández, et al.. (2025). Multikinase Treatment of Glioblastoma: Evaluating the Rationale for Regorafenib. Cancers. 17(3). 375–375. 2 indexed citations

Pineda, Estela, Ainhoa Hernández, Marta Doménech, et al.. (2024). The C250T Mutation of TERTp Might Grant a Better Prognosis to Glioblastoma by Exerting Less Biological Effect on Telomeres and Chromosomes Than the C228T Mutation. Cancers. 16(4). 735–735. 1 indexed citations

Candal‐Pedreira, Cristina, Alberto Ruano‐Raviña, Virginia Calvo, et al.. (2024). Analysis of Diagnostic Delay and its Impact on Lung Cancer Survival: Results From the Spanish Thoracic Tumor Registry. Archivos de Bronconeumología. 60. S38–S45. 1 indexed citations

Carcereny, Enric, Maria Saigí, Anna Esteve, et al.. (2023). P1.21-04 Role of HLA-I as a Molecular Prognostic Factor for Long Term Responders in Non-small Cell Lung Cancer Patients Treated with Immunotherapy. Journal of Thoracic Oncology. 18(11). S235–S235. 1 indexed citations

Cucurull, Marc, Carolina Sanz, Enric Carcereny, et al.. (2023). Characterization of a cohort of metastatic lung cancer patients harboring KRAS mutations treated with immunotherapy: differences according to KRAS G12C vs. non-G12C. Frontiers in Oncology. 13. 1239000–1239000. 2 indexed citations

Pineda, Estela, et al.. (2023). Recurrent Glioblastoma: Ongoing Clinical Challenges and Future Prospects. OncoTargets and Therapy. Volume 16. 71–86. 20 indexed citations

Hernández, Ainhoa, Eudald Felip, Marc Cucurull, et al.. (2022). Immune Response and Effects of COVID-19 Vaccination in Patients with Lung Cancer—COVID Lung Vaccine Study. Cancers. 15(1). 137–137. 4 indexed citations

Hernández, Ainhoa, Ana M Muñoz‐Mármol, Anna Esteve‐Codina, et al.. (2022). In silico validation of RNA-Seq results can identify gene fusions with oncogenic potential in glioblastoma. Scientific Reports. 12(1). 14439–14439. 2 indexed citations

Balañá, Carmen, Sara Castañer, Cristina Carrato, et al.. (2022). Preoperative Diagnosis and Molecular Characterization of Gliomas With Liquid Biopsy and Radiogenomics. Frontiers in Neurology. 13. 865171–865171. 18 indexed citations

10.

Saigí, Maria, Enric Carcereny, Teresa Morán, et al.. (2022). Biological and clinical perspectives of the actionable gene fusions and amplifications involving tyrosine kinase receptors in lung cancer. Cancer Treatment Reviews. 109. 102430–102430. 6 indexed citations

11.

Felip, Eudald, Edwards Pradenas, Margarita Romeo, et al.. (2022). Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS‐CoV ‐2 mRNA ‐1237 vaccine in patients with solid tumors. Molecular Oncology. 17(4). 686–694. 3 indexed citations

12.

Riudavets, Mariona, Joaquim Bosch‐Barrera, Luis Cabezón‐Gutiérrez, et al.. (2021). Efficacy of nintedanib plus docetaxel in patients with refractory advanced epidermal growth factor receptor mutant lung adenocarcinoma. Clinical & Translational Oncology. 23(12). 2560–2567. 7 indexed citations

13.

Taus, Álvaro, Pedro Rocha, Ainhoa Hernández, et al.. (2021). Plasmatic KRAS Kinetics for the Prediction of Treatment Response and Progression in Patients With KRAS-mutant Lung Adenocarcinoma. Archivos de Bronconeumología. 57(5). 323–329. 2 indexed citations

14.

Doménech, Marta, Ana M Muñoz‐Mármol, José Luís Mate, et al.. (2021). Correlation between PD-L1 expression and MET gene amplification in patients with advanced non-small-cell lung cancer and no other actionable oncogenic driver. Oncotarget. 12(18). 1802–1810. 12 indexed citations

15.

Doménech, Marta, Ainhoa Hernández, Andrea Plaja, Eva Martinez‐Balibrea, & Carmen Balañá. (2021). Hypoxia: The Cornerstone of Glioblastoma. International Journal of Molecular Sciences. 22(22). 12608–12608. 115 indexed citations

16.

Hernández, Ainhoa, Marta Doménech, Ana M Muñoz‐Mármol, Cristina Carrato, & Carmen Balañá. (2021). Glioblastoma: Relationship between Metabolism and Immunosuppressive Microenvironment. Cells. 10(12). 3529–3529. 26 indexed citations

17.

Taus, Álvaro, Pedro Rocha, Ainhoa Hernández, et al.. (2020). Plasmatic KRAS Kinetics for the Prediction of Treatment Response and Progression in Patients With KRAS-mutant Lung Adenocarcinoma. Archivos de Bronconeumología. 57(5). 323–329. 2 indexed citations

18.

Taus, Álvaro, Ainhoa Hernández, Eva López, et al.. (2017). P1.02-039 Assessment of KRAS mutations (by Digital PCR) in Circulating Tumoral DNA from Lung Adenocarcinoma Patients. Journal of Thoracic Oncology. 12(1). S511–S511. 1 indexed citations

19.

Balañá, Carmen, Ainhoa Hernández, Pedro Pérez‐Segura, et al.. (2017). SEOM clinical guidelines for anaplastic gliomas (2017). Clinical & Translational Oncology. 20(1). 16–21. 8 indexed citations

20.

Neninger, Elia, et al.. (2008). 505 POSTER Preliminary results of a phase II clinical trial of the anti EGFR monoclonal antibody Nimotuzumab in combination with whole brain radiation therapy in patients diagnosed with advanced non-small cell lung cancer tumors unresectable brain metastases. European Journal of Cancer Supplements. 6(12). 160–161. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact